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Abstract
Multivariate regression models for age estimation are a powerful tool for assessing abnormal brain morphology
associated to neuropathology. Age prediction models are built on cohorts of healthy subjects and are built to reflect
normal aging patterns. The application of these multivariate models to diseased subjects usually results in high prediction
errors, under the hypothesis that neuropathology presents a similar degenerative pattern as that of accelerated aging. In
this work, we propose an alternative to the idea that pathology follows a similar trajectory than normal aging. Instead,
we propose the use of metrics which measure deviations from the mean aging trajectory. We propose to measure these
deviations using two different metrics: uncertainty in a Gaussian process regression model and a newly proposed age
weighted uncertainty measure. Consequently, our approach assumes that pathologic brain patterns are different to
those of normal aging. We present results for subjects with autism, mild cognitive impairment and Alzheimer’s disease
to highlight the versatility of the approach to different diseases and age ranges. We evaluate volume, thickness, and
VBM features for quantifying brain morphology. Our evaluations are performed on a large number of images obtained
from a variety of publicly available neuroimaging databases. Across all features, our uncertainty based measurements
yield a better separation between diseased subjects and healthy individuals than the prediction error. Finally, we
illustrate differences in the disease pattern to normal aging, supporting the application of uncertainty as a measure of
neuropathology.
1. Introduction
The brain is a complex organ whose morphology varies
substantially across the population. The causes of mor-
phological variation have not yet been fully understood,
but several studies have reported on potential causal fac-
tors including age (Guttmann et al., 1998; Franke et al.,
2010; Ziegler et al., 2012; Wachinger et al., 2015), sex (In-
galhalikar et al., 2014), pathologies like dementia (Gaser
et al., 2013; Wachinger et al., 2016), and even environmen-
tal factors such as education and physical activity (Stef-
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fener et al., 2016). Among all these variables, age was
shown to be the main factor determining brain morphol-
ogy (Potvin et al., 2017). Due to the wide impact of aging
on brain morphology, multivariate regression methods us-
ing features based on brain morphology can in turn be
used to estimate a subject’s age. A recent volume of work
has focused on modeling the normal aging of healthy indi-
viduals to predict a subject’s age. Obtaining a prediction
of the age with imaging features was shown to be use-
ful to derive imaging biomarkers, which can potentially be
used to predict brain anomaly caused by disease (Cole and
Franke, 2017).
The task of predicting age from brain images has been
formulated as multivariate regression, where a predictive
model is trained to relate structural information obtained
from brain MR images to the chronological age of healthy
subjects (Gaser et al., 2013; Wang et al., 2014; Kondo
et al., 2015; Valizadeh et al., 2017; Liem et al., 2017).
The prediction from these models is interpreted as an es-
timate of a subject’s biological age, in contrast to a sub-
ject’s chronological age. Of particular interest is the pre-
diction error, which is defined as the difference between
the biological and chronological age (figure 1a). When
predicting the age of healthy subjects, the prediction error
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is assumed to be small, while the prediction on subjects
with neuropathology is assumed to result in large posi-
tive prediction errors. The error could therefore serve as
a personalized marker of pathological processes (Franke
et al., 2010; Gaser et al., 2013). The main assumption be-
hind using the prediction error as a measure of pathology
is that changes caused by neuropathology are equivalent
to an accelerated aging process. Following this hypoth-
esis, Gaser et al. (2013) and Habes et al. (2016) showed
that changes related to Alzheimer’s disease (AD) resem-
ble accelerated aging, since differences between biological
and chronological age are larger for individuals with AD
than for healthy controls. Similar results on age differ-
ences have also been reported for individuals diagnosed
with schizophrenia (Nenadic et al., 2017) and depression
(Koutsouleris et al., 2013). In these studies, the age pre-
diction model is trained using only images from healthy
individuals. This means that contrary to their discrimi-
native counterparts, a single age prediction model can be
used to assess differences between healthy controls and in-
dividuals diagnosed with different conditions.
Although the findings of these studies show the big po-
tential of using models of healthy aging to assess brain ab-
normality, a potentially limiting factor when quantifying
neuropathology through the difference between chronolog-
ical and predicted age, is the assumption that morpholog-
ical changes caused by disease follow an accelerated aging
process. The assumption that brain anomaly is equiva-
lent to accelerated aging may hold true for specific brain
regions that accommodate neural systems with high sus-
ceptibility to deleterious factors, which are therefore af-
fected by aging and disease processes. However, the as-
sumption of accelerated aging does likely not extend to
the whole brain, given that differences in brain morphol-
ogy are caused by a variety of neurobiological processes
that are complex and non-linear (Fjell et al., 2014; Buck-
ner, 2004; Hedden and Gabrieli, 2004). This is potentially
problematic, as current approaches for predicting the brain
age are based on multivariate regression models that oper-
ate on gray matter maps or morphological features across
the entire brain.
In this work, we build on the idea of modeling neu-
ropathology as deviations from the healthy development of
the brain. Our main hypothesis is that disease and aging
result in brain-wide patterns of change. These patterns are
not independent from each other and are essentially similar
for several brain regions where disease results in patterns
resembling accelerated aging. However, these accelerated
aging patterns do not extend to the whole brain, mak-
ing the assessment of deviations from healthy aging solely
through prediction error problematic. We propose instead
the use of Gaussian process regression (GPR). GPR can
measure how a new subject deviates from previous obser-
vations used to construct the model by means of the pos-
terior prediction uncertainty. Different to prediction error,
GPR uncertainty is able to measure deviations from the
healthy aging model without the implicit assumption of a
brain-wide accelerated aging pattern. Particularly for the
task of age prediction, we introduce a variation to tradi-
tional Gaussian processes regression that takes the known
chronological age into account. This modification yields
a weighted uncertainty measure. We evaluate our new
method on a large collection of images obtained from sev-
eral public datasets for assessing the variation to normal
aging in mild cognitive impairment, Alzheimer’s disease,
and autism. Our results support the use of Gaussian pro-
cess uncertainty and the age weighted uncertainty as tools
to measure neuropathological patterns that deviate from
healthy aging. Similar to previous age prediction mod-
els, our evaluations are done with a single age prediction
model which is trained only on healthy controls, showing
its versatility across different age ranges and diseases.
2. Materials and Methods
2.1. Method overview
In this section, we describe our method for assess-
ing neuropathology based on GPR uncertainty. Figure 2
presents an overview of our method, which consists of two
stages. In the training stage (top section of figure 2), we
build a GPR model that estimates the chronological age
of healthy subjects. This model is built using a dataset
of MRI scans of healthy controls (section 2.2). Images are
processed and segmented to extract a set of features de-
scribing brain morphology (section 2.3). Finally, a GPR
model mapping the extracted features to a predicted age
is trained on these features (section 2.4).
In the testing stage (bottom section of figure 2), we use
the GPR model trained on healthy subjects to quantify
deviations from the normal aging pattern on previously
unseen subjects. In this stage, morphological features are
extracted from the MR images of the test subjects, and
these features are then used to obtain an estimate of the
age of the subject using the GPR model. From the GPR
model, we obtain the estimated age yˆ, an uncertainty mea-
sure of the estimation cov(yˆ), and a weighted uncertainty
measure covw(yˆ) (see section 2.4.1 for details on these
measurements). We will show in our experiments (section
3) that these measurements based on the uncertainty of the
GPR model can be used to assess the similarity between
subjects in the testing set and the healthy population in
the training set.
2.2. Data
Similar to previous work on age prediction, we train an
age regression model based on T1-MR images of healthy
individuals. The training images for our age regression
model are extracted from three different databases: IXI 1,
ABIDE (Di Martino et al., 2014), and AIBL (Ellis et al.,
2009). Details for each training dataset are shown in ta-
ble 1. We perform evaluation on 3 different test datasets
1http://brain-development.org/ixi-dataset/
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(a) Prediction error . A series of data points are plotted
showing their chronological age y and their predicted bio-
logical age yˆ. Training points used to train the model are
shown in blue. Prediction error  for a test point is defined
as the difference between its predicted biological age and its
chronological age.
(b) Prediction uncertainty cov(yˆ). Data points are plotted on
the feature space determined by two volumetric features. Circles
correspond to training subjects and non circles to testing subjects.
Uncertainty cov(yˆ) measures the distance of a testing point to
all training points in the feature space. The background color
corresponds to uncertainty in the feature space. Areas close to
the training points have lower degrees of uncertainty. The color
of each subject encodes its chronological age.
(c) Weighted Uncertainty covw(yˆ). Data points are shown on an extended feature space given by two volumetric features and
their corresponding chronological age y. Weighted uncertainty covw(yˆ) measures the distance of a testing point to all training
points in this extended feature space.
Figure 1: Comparison between the three evaluated anomaly metrics: prediction error , GPR uncertainty cov(yˆ) and GPR age-weighted
uncertainty covw(yˆ).
summarized in table 2. The training and testing groups
are therefore extracted from different databases and are
independent from each other. For the first and second
groups, obtained from the OASIS (Marcus et al., 2007)
and ADNI (Jack et al., 2008) datasets, we aim at find-
ing differences between Healthy Controls (HC), individu-
als diagnosed with Mild Cognitive Impairment (MCI), and
subjects diagnosed with Alzheimer’s disease (AD). For the
3
Figure 2: Overview of our brain anomaly prediction model. The top part corresponds to the training stage where a set of images from healthy
individuals is used to build a GPR age prediction model. The bottom part corresponds to the age prediction stage where the GPR model
is used to predict the age of a set of test images. A predicted age yˆ as well as the uncertainty measures cov(yˆ) and covw(yˆ) are obtained.
These measurements can be used to find differences between the HC and Dx groups.
third dataset, ABIDE II, we look for differences between
HC and individuals diagnosed with autism. In total, 1,543
images were used for training and 4,819 images for testing.
2.3. Feature Extraction
As mentioned in the overview section of our method,
we require to extract features from structural MR im-
ages to quantify the brain morphology. Several image
based features have previously been used for the age es-
timation task: Good et al. (2001), Franke et al. (2010)
and Gaser et al. (2013) used Voxel Based Morphometry
(VBM) features, which identify differences on the compo-
sition of brain tissue by registering all structural images
to the same space. After segmenting gray and white mat-
ter, the voxel values of the gray matter extracted images
are used as features. Finally the dimensionality of the fea-
ture space is reduced using Principal Component Analysis
(PCA) and keeping only the principal modes of variation.
Valizadeh et al. (2017) and Wang et al. (2014) use volumet-
ric, thickness and curvature measurements of the brain, de-
rived from the brain segmentation with FreeSurfer (Fischl,
2012). These different sets of features have been presented
in separate studies but, to the best of our knowledge, have
not yet been directly compared on the same age estimation
task. In summary, we use three different types of features
in our approach:
• VBM features (50 Principal Components),
• Thickness of 70 cortical structures.
• Volume of 50 brain structures.
Additionally we build a prediction model combining VBM,
thickness and volume features together. VBM features
were extracted using the CAT12 toolbox 2 together with
the SPM12 toolbox 3 for segmentation. The preprocess-
ing of the images, the segmentation of gray matter, and
post processing were implemented in line with the pipeline
proposed by Franke et al. (2010). Dimensionality reduc-
tion was performed using the PCA library included in the
scikit-learn toolbox (Pedregosa et al., 2011). The princi-
pal component directions were estimated using only the
training sample, and the testing data was projected to
this estimated lower dimensional space. For all the anal-
yses on thickness and volume features, FreeSurfer version
5.3 was used. The default Deskian/Killiany atlas was used
for the parcellation to obtain thickness measurements. We
are using all subcortical volume measurements as provided
by FreeSurfer and described in the FreeSurfer subcortical
segmentation pipeline.
2http://www.neuro.uni-jena.de/cat/
3http://www.fil.ion.ucl.ac.uk/spm/
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Training Dataset No. Images Female/Male Age (Min-Max) Age Quantiles
IXI 581 311/270 19-87 33.7 - 48.6 - 62.2
ABIDE I 573 99/474 6-64 14.6 - 17.0 - 20.1
AIBL 409 209/200 55-92 67.0 - 73.0 - 79.0
Table 1: Summary of the datasets used for training the age prediction model.
Testing Dataset No. Images Female/Male Age (Min-Max) Age Quantiles Target Dx
ADNI 3591 1422/2169 54-90 71.2 - 75.1 -79.7 MCI - AD
OASIS 196 129/67 60-82 71.0 - 76.0 - 82.0 MCI - AD
ABIDE II 1032 247/785 5-64 9.5 - 11.4 - 15.2 Autism
Table 2: Summary of the datasets used for testing.
2.4. Uncertainty Estimation with Gaussian Process Re-
gression
Several multivariate regression techniques have been
previously used for the task of age prediction from brain
MR images. A detailed comparison of the performance of
neural networks, random forests, k-nearest neighbors, sup-
port vector machines, multiple linear regression and ridge
regression was presented by (Valizadeh et al., 2017). In
the work by Franke et al. (2010) relevance vector regres-
sion was preferred.
In our case, we are interested in modeling the age re-
gression problem with a model that does not only provide
estimates of the biological age, but also provides uncer-
tainties of these estimates. Gaussian process regression
achieves a comparable accuracy in age regression than
standard regression techniques, while offering the advan-
tage of providing an estimate of the uncertainty of each
prediction. GPR models have been used successfully be-
fore as age prediction models (Cole et al., 2015, 2016), but
the potential of using uncertainty based measurements as
biomarkers has not been explored yet. In this section, we
will briefly introduce GPR models, focusing particularly
on the calculation of uncertainty, where we refer the reader
to (Rasmussen and Williams, 2005) for a more detailed ex-
planation, and introduce our modification for computing
an age-weighted uncertainty.
2.4.1. Gaussian Process
A Gaussian process is defined as a collection of random
variables, any finite number of which have a joint Gaussian
distribution (Rasmussen and Williams, 2005) with:
• a mean function m(x) = E[f(x)],
• and a covariance function k(x,x′) = E[f(x)−m(x)f(x′)−
m(x′)].
Although not necessary, it is often assumed that the mean
function m(x) of the GPR is zero. Therefore the design
of a GPR is focused on the selection of an appropriate
covariance function k(x,x′) measuring the similarity be-
tween data points. This covariance function is equivalent
to a similarity measure between two data points, giving
small values for points that are close to each other and
large values otherwise. In our case we define the covariance
function as a squared exponential function of the form:
k(xi,xj) =
K∑
k=1
exp
[−(xki − xkj )2
2l2k
]
+ σ2nδ(xi,xj), (1)
where σ2n is the noise variance, l
k is the length scale of the
k-th feature, and δ is the Kronecker delta function. We
can think of the length scale vector l ∈ RK as a parameter
controlling how close should two data points xi and xj
should be in order to influence each other. In general, the
smaller an element lk is, the more dependent y is to the
feature element xk.
We model the joint distribution of the training and test
outputs as:[
y
y′
]
∼ N
(
0,
[
K(X,X) K(X,X′)
K(X′,X) K(X′,X′)
])
. (2)
The elements of the joint distribution in Eq.(2) can be
summarized as follows:
• an intra-covariance matrix of the training setK(X,X) ∈
Rmxm ,
• an intra-covariance matrix of the testing setK(X′,X′) ∈
Rnxn,
• an inter-covariance matrix between the training and
testing set K(X,X′) ∈ Rmxn,
• a training labels vector y ∈ Rm, and
• a testing labels vector y′ ∈ Rn,
where m corresponds to the number of training samples
and n to the number of testing samples. The matrices
K(X,X) have the form:
K =

k(x1,x1) k(x1,x2) . . . k(x1,xn)
k(x2,x1) k(x2,x2) . . . k(x2,xn)
...
...
. . .
...
k(xm,x1) k(xm,x2) . . . k(xm,xn)
 , (3)
where each element k(x1,x2) corresponds to a measure of
the similarity between two feature vectors xi and xj . We
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are interested in predicting the values for the test labels
y′, which have the following conditional distribution:
(4)y′|y,X,X′ ∼ N (K(X′,X),K(X,X)−1y,K(X′,X′)
−K(X′,X)K(X,X)−1K(X,X′)).
Using this conditional distribution we can derive the
predictive equations of a GPR:
yˆ′ = E[yˆ′|X, yˆ,X′] = K(X′,X)K(X,X)−1y (5)
cov(yˆ) = K(X′,X′)−K(X′,X)K(X,X)−1K(X,X′),
(6)
which correspond to the predicted labels and to the esti-
mated covariance, respectively. The estimated covariance
can also be thought as a measure of uncertainty for the pre-
dicted values. This uncertainty estimate is usually used in
the GPR framework to measure the degree of confidence
of a predicted value yˆ′ by measuring the similarity of a
new observation with respect to the previous observations
in the training set.
When training a GPR model, the parameters θ = {l, σn}
have to be tuned in order to fit the training data. This is
done by maximizing the marginal likelihood of the model
given by:
(7)
log(p(y|X, θ)) = −1
2
yTK(X,X)y
− 1
2
log(K(X,X))− n
2
log(2pi).
By finding the parameters θ that maximize the marginal
likelihood, we can obtain a GPR model that best fits the
training data.
2.4.2. Age-Weighted Uncertainty
The uncertainty measurement of the GPR cov(yˆ) is
solely defined with respect to the feature vectors x. In
a common regression scenario this is a natural approach
since the real values of the labels are unknown. However,
in the case of an age estimation framework, we do pos-
sess the real values of the labels, which correspond to the
chronological age of the patient.
We can introduce the age information into the GPR
framework by creating age-weighted similarity matrices
Kw(X,X
′,y,y′). Similar to the GPR covariance matri-
ces we can construct three different similarity matrices:
• a weighted intra-similarity matrix for the training
samples Kw(X,X,y,y) ∈ Rmxm ,
• a weighted intra-similarity matrix for the testing sam-
ples Kw(X
′,X′,y,y′) ∈ Rnxn, and
• a weighted inter-similarity matrix between the train-
ing and test samples Kw(X,X
′,y,y′) ∈ Rmxn.
These similarity matrices are constructed in the same
manner as the covariance matrices presented in section
2.4.1. The only difference consists in a modification of
the kernel to take into account differences in age. This is
achieved by creating an age weighted similarity kernel of
the form:
kw(xi,xj ,yi,yj) = s(yi,yj)k(xi,xj), (8)
where k(xi,xj) corresponds to the kernel defined in Eq.(1)
and s(yi,yj) corresponds to an age similarity term defined
as:
s(yi,yj) = exp
[−(yi − yj)2
2l2y
]
+ σ2yδ(yi,yj). (9)
where ly corresponds to the age length scale, which is a
parameter controlling the effect of the age weighting. By
using this updated kernel kw, we obtain a weighted uncer-
tainty term covw(y) which takes into account the age of
the subjects to define similarities between subjects. This
weighted uncertainty is obtained similar to the regular un-
certainty presented in Eq. (6):
covw(y
′) = Kw(X′,X′)−Kw(X′,X)Kw(X,X)−1Kw(X,X′).
(10)
2.5. Prediction Error, Uncertainty and Age-Weighted Un-
certainty
In this work, we compare three age regression based
metrics in order to measure their usefulness as a biomarker
to distinguish between healthy controls and subjects with
different neuropathologies. These metrics are the com-
monly used prediction error  = yˆ−y (Franke et al., 2010),
the GPR uncertainty cov(y), and the GPR age-weighted
uncertainty covw(y). As discussed in the introduction, the
prediction error has previously been used to assess differ-
ences between healthy and non-healthy populations. The
prediction error is the difference between the predicted and
chronological age, as shown in figure 1a. A higher pre-
diction error is assumed to indicate an accelerated aging
process (Franke et al., 2010; Gaser et al., 2013).
The computation of the GPR uncertainty cov(yˆ) was
presented in section 2.4.1. It can be thought of as a metric
on how close a testing point is to all the training points
in the feature space, illustrated in figure 1b. The scatter
plot represents a set of subjects in a 2-dimensional space
composed of the volume of two different structures. By
training a GPR on a set of training points (represented
by circles), we obtain a measure of uncertainty cov(yˆ) for
every point in the 2D-space. This covariance matrix is rep-
resented by the shading of the grid, where darker regions
correspond to regions where the predictor has higher con-
fidence on its prediction. When performing prediction on
previously unseen points (Test Subject 1 and Test Subject
2), we can obtain both a predicted age yˆ and its confi-
dence cov(yˆ). In figure 1b, we observe that even though
6
both test subjects get similar predicted values, the confi-
dence of the prediction for subject two is higher due to its
proximity to the training set.
The third metric, the age-weighted uncertainty covw(yˆ)
expands upon the notion of uncertainty by taking into ac-
count the subject’s age. Measuring covw(yˆ) is equivalent
to adding a further dimension to the distance measured by
the normal GPR uncertainty. The reasoning behind this
is to give higher similarity to individuals which have simi-
lar morphological features to healthy individuals of similar
ages. For example, we see in figure 1c that a healthy test-
ing point (blue) is close to training points with similar
features and age; the testing point would therefore have a
high covw(yˆ) value. On the other hand, the Testing Point
corresponding to a diseased subject (red point) would have
a low covw(yˆ) value because even though there are indi-
viduals in the training set with similar feature values, they
correspond to subjects with a different age range. Both
proposed metrics are closely related. In fact, cov(yˆ) is
equivalent to covw(yˆ) for the special case when ly =∞.
2.6. Aging and Disease Assessment
As discussed in the introduction, several studies have
demonstrated that aging is a complex process, which af-
fects different brain structures and regions at different
rates of change. It has also been reported that deleteri-
ous changes caused by neurodegenerative disease follow a
pattern that resembles an accelerated aging process. In or-
der to evaluate how aging and neurodegenerative disease
affect different brain regions, we performed an analysis of
the volumetric features obtained from our training set. To
facilitate this analysis we restricted our analysis to images
obtained from the ADNI database. To assess which indi-
vidual structures are affected either by aging, disease or
both factors, a series of simple linear fixed effects model
were fitted to our data. In each one of these models, the
dependent variable corresponds to the volume of a different
brain structure, and the independent variables correspond
to age, sex, diagnosis (0 = healthy, 1 = MCI/AD) and an
interaction term between diagnosis and age.
3. Results
3.1. Assessing the Effect of Aging and Disease on Brain
Development
In this section we present the results obtained after
fitting the aging and disease model described in section
2.6. In table 3, we present the regression coefficients for
age, diagnosis and the age/diagnosis interaction term as
well as their corresponding p-values for the linear fixed
effects model. The table is sorted by descending p-value
for the diagnostic coefficient, which means that the struc-
tures at the top of the table are those which present more
significant volume alterations caused by disease. Age and
volume variables were normalized in order to make the co-
efficients of different structures comparable. In the case
of bilateral structures we only show the values for the left
hemisphere in order to simplify our analysis. Plots show-
ing the progress of the hippocampus and cerebellum white
matter across different ages for both healthy and individ-
uals with MCI/AD are also presented to illustrate our re-
sults in figure 3. The hippocampus was selected since it
was the structure which had the most evident effects of
age and disease. On the other hand, the cerebellum white
matter was selected as a structure which showed signifi-
cant effects of aging but is apparently not largely affected
by Alzheimer’s disease.
There are a couple of relevant observations that can be
extracted from table 3. First, the regression coefficients
for age and diagnosis always have the same sign for struc-
tures with significant associations, and there exist signif-
icant interactions between aging and diagnosis for most
of the analyzed structures. This supports the hypothe-
sis that disease and aging are overlapping processes that
affect the brain structures in the same direction. How-
ever, we can also observe in table 3 that there exist some
structures that although largely affected by aging do not
present significant disease effects (i.e. cerebellum white
matter). This can also be observed on the box plots in the
top of figure 3, where a clear difference between the HC
and Dx groups is evident for all age ranges in the case of
the hippocampus, whereas for the cerebellum white matter
no significant differences exist between both groups.
To further illustrate the point that aging and disease
are processes that affect different regions of the brain at
different rates, we show the progress of pairs of features
for both the HC and Dx groups (bottom of figure 3). By
looking at the central plot, where the volume of left and
right hippocampus is shown, we can understand the rea-
soning behind the accelerated aging hypothesis of previous
age estimation works. Indeed, by looking only at these fea-
tures, we would be tempted to conclude that the brain of
a healthy 80 year old is essentially similar to that of a
diseased 60 year old. However, this observation contrasts
with the left plot, where the left and right cerebellum white
matter volumes are shown. By looking at these features
alone, we would draw a different conclusion, since it would
appear that there are no differences between the brains of
healthy and diseased subjects of the same age. By looking
at the left hippocampus and left cerebellum white mat-
ter simultaneously (right in figure 3), we can observe that
disease produce changes in the brain that are essentially
different to those of accelerated aging, causing the overall
appearance of the brain of an average 60 year old diagnosed
with AD to be different to a healthy individual of any age.
These observations support our hypothesis that morpho-
logical changes associated to AD and MCI are complex
and that a model of accelerated aging across the whole
brain may be too simplistic to model the specific effects of
disease and aging at specific brain structures.
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Figure 3: Top: Box plots showing changes in left cerebellum white matter volume and hippocampus volume for individuals between 50 and
80 years old. Bottom: Plots showing age progression of feature pairs for three different cases; left: structures that are not affected by disease;
center: structures affected by disease that show an accelerated aging pattern; right: one structure affected by disease (left hippocampus) and
one structure with no significant disease effect (left cerebellum white matter).
3.2. Training of the Age Prediction Model
Using the training datasets summarized in table 1, we
train 4 different GPR models, each one with a different
set of features as described in section 2.3. Each one of the
GPR models is trained to estimate the age of healthy sub-
jects based on either volume, thickness, VBM features or a
combination of all features. Our models were implemented
using python together with the scikit-learn toolbox. In ta-
ble 4, we show the Mean Absolute Error (MAE) and R2
score for the training set, using a 5-fold cross validation.
Our model presents similar MAE and R2 when compared
to previous work on age estimation (Valizadeh et al., 2017;
Cole et al., 2016). Similar to previously reported results
(Valizadeh et al., 2017), we observed higher R2 score and
lower MAE for the model trained using an ensemble of all
available features. The chronological and predicted age for
each subject in the training set are presented in the scatter
plots in figure 4.
3.3. Evaluation of Gassian Process Uncertainty as a Mea-
sure of Brain Abnormality
In this section, we present results of our experiments
comparing the use of prediction error , uncertainty cov(yˆ)
and age-weighted uncertainty covw(yˆ) as a biomarker for
differentiating between healthy controls and patients with
MCI, AD or autism. We performed three different ex-
periments: the first two experiments are targeted at find-
ing differences between HC, MCI and AD groups in both
the ADNI and OASIS databases; the third experiment is
performed on the ABIDE II database where differences be-
tween autism and healthy groups are evaluated. Note that
as summarized in tables 1 and 2, the datasets used for test-
ing are different to those used for training. For all experi-
ments we assessed differences between groups both by per-
forming non-parametric Wilcoxon rank-sum tests (Mann
and Whitney, 1947) and by measuring the classification
performance in a per subject basis by generating Receiver
Operating Characteristic (ROC) curves with their corre-
sponding Area Under the Curve (AUC) values. For all
experiments, results are shown for four different sets of
features: volume, thickness and VBM, as well as for the
combination of all three feature sets. Our proposed GPR
uncertainty based metrics are compared to the prediction
error , obtained in a similar fashion as previous work on
age estimation (Franke et al., 2010). An appropriate age
length scale parameter ly for the covw(yˆ) metric was set
independently for each experiment by performing evalu-
ations at different scales an keeping the best performing
results (See figure 5).
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Figure 4: Scatter plots showing the prediction results of the age prediction models trained using different feature sets.
  
 
  
 
  
 
  
 
  
 
  
 
  
 
 O H Q J W K  V F D O H
     
     
     
     
     
 $ 8
 &
 2 $ 6 , 6
  
 
  
 
  
 
  
 
  
 
  
 
  
 
 O H Q J W K  V F D O H
     
     
     
     
     
     
 $ 8
 &
 $ ' 1 ,
  
 
  
 
  
 
  
 
  
 
  
 
  
 
 O H Q J W K  V F D O H
     
     
     
     
     
     
     
     
     
 $ 8
 &
 $ % , ' (  , ,
Figure 5: AUC values obtained by using the covw(yˆ) metric for different age length scales ly . According to this curves, a different length
scale was selected for each experiment (ADNI: ly =1× 102, OASIS: ly =1× 105, ABIDE: ly =1). The selected length scales are highlighted
in red in each plot.
3.3.1. Experiment 1: ADNI Dataset
For our first experiment we measure the separation be-
tween HC, MCI and AD groups for images obtained from
the ADNI database. Due to the very large dataset size of
this testing scenario, all the p-values reported in table 5 are
statistically significant (p-value< 6× 10−5). The reported
AUC values in table 6 and the ROC curves in figure 6 show
consistently a better performance of the uncertainty based
metrics cov(yˆ) and covw(yˆ) with respect to . In general
cov(yˆ) and covw(yˆ) presented similar performance, but
adding the age term resulted in larger AUC values for the
experiments on volume and VBM features. Box plots for
each feature set and each diagnostic group are also shown
in figure 7. The results using uncertainty based measures
cov(yˆ) and covw(yˆ) were strongly correlated (R =0.95).
In contrast, correlations of 0.35 and 0.37 were obtained
between -cov(yˆ) and -covw(yˆ), respectively.
3.3.2. Experiment 2: OASIS Dataset
Our second experiment is similar to experiment 1, but
our evaluation is performed on images obtained from the
OASIS database. In order to ensure similar age ranges
for the HC, MCI and AD groups, all individuals under 60
years were removed from the testing dataset. Tables 7 and
8 summarize the numerical results of the comparisons be-
tween HC-MCI and MCI-AD groups. Similar to previous
results (Franke et al., 2010), we observed that prediction
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Figure 6: Receiver Operating Characteristic (ROC) curves for the prediction of the presence of MCI/AD (Top) or the presence of AD (Bottom)
evaluated on the ADNI dataset. Columns correspond to the different evaluated features.
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Figure 7: Box plots showing prediction results for  (top), cov(yˆ) (middle) and covw(yˆ) (bottom) for HC, MCI and AD groups on the ADNI
dataset. Columns correspond to the different evaluated features.
error  is a useful biomarker in this particular dataset. Ac-
cording to the results in tables 7 and 8,  presented larger
AUC values and smaller p-values for the models trained
using volume and thickness features when discriminating
between HC and MCI groups. However for all the rest
of the evaluations on the OASIS database, cov(yˆ) and
covw(yˆ) presented the best performance amongst the eval-
uated metrics. Correlation coefficients between the met-
rics were 0.99 for cov(yˆ)-covw(yˆ), 0.38 for -cov(yˆ) and
0.38 for -covw(yˆ). Notice that in this case the results
for cov(yˆ) and covw(yˆ) are strongly correlated due to the
very large value assigned to the age length scale parameter
10
T
a
b
le
3
:
C
o
effi
ci
en
ts
a
n
d
p
-v
a
lu
es
co
rr
es
p
o
n
d
in
g
to
th
e
li
n
ea
r
m
o
d
el
s
fi
tt
ed
to
p
re
d
ic
t
v
o
lu
m
e
o
f
in
d
iv
id
u
a
l
st
ru
ct
u
re
s.
S
tr
u
ct
u
re
s
a
re
so
rt
ed
b
y
d
es
ce
n
d
in
g
p
-v
a
lu
e
fo
r
d
ia
g
n
o
st
ic
.
S
tr
u
ct
u
re
A
ge
C
o
effi
ci
en
t
D
x
C
o
effi
ci
en
t
A
ge
×
D
x
C
o
effi
ci
en
t
A
g
e
p
-v
a
lu
e
D
x
p
-v
a
lu
e
A
g
e
×
D
x
p
-v
a
lu
e
L
ef
t.
H
ip
p
o
ca
m
p
u
s
-0
.3
0
-0
.5
3
0.
03
9.
1
2
×
1
0
−
1
0
7
4.
0
4
×
1
0
−
2
9
1
2
.8
7
×
1
0
−
2
L
ef
t.
A
m
y
gd
al
a
-0
.2
1
-0
.4
1
0.
07
4
.1
3
×
1
0
−
5
0
1
.5
3
×
1
0
−
1
6
9
1
.6
7
×
1
0
−
5
L
ef
t.
In
f.
L
at
.V
en
t
0.
27
0.
38
-0
.0
7
1.
7
7
×
1
0
−
7
0
1.
5
0
×
1
0
−
1
4
1
3
.0
0
×
1
0
−
5
L
ef
t.
L
at
er
al
.V
en
tr
ic
le
0.
22
0.
24
-0
.0
9
8
.3
8
×
1
0
−
4
6
1
.8
4
×
1
0
−
5
7
1
.3
2
×
1
0
−
7
C
S
F
0.
16
0.
22
-0
.1
1
1.
0
7
×
1
0
−
2
3
1.
8
5
×
1
0
−
4
6
5
.9
5
×
1
0
−
1
1
L
ef
t.
A
cc
u
m
b
en
s.
ar
ea
-0
.3
0
-0
.2
2
0.
07
2
.7
5
×
1
0
−
7
5
1
.4
8
×
1
0
−
4
3
7
.8
9
×
1
0
−
5
3r
d
.V
en
tr
ic
le
0.
27
0.
19
-0
.1
3
1.
0
4
×
1
0
−
7
0
1.
5
3
×
1
0
−
3
6
3
.4
9
×
1
0
−
1
5
L
ef
t.
ch
or
oi
d
.p
le
x
u
s
0.
14
0.
17
-0
.0
4
2.
0
4
×
1
0
−
1
8
1
.5
9
×
1
0
−
2
7
2
.1
6
×
1
0
−
2
L
ef
t.
P
u
ta
m
en
-0
.1
5
-0
.1
4
0.
02
9.
8
4
×
1
0
−
2
1
2.
1
5
×
1
0
−
1
7
0
.3
0
L
ef
t.
V
en
tr
al
D
C
-0
.2
7
-0
.1
1
-0
.0
3
7.
0
9
×
1
0−
7
1
3.
3
8
×
1
0
−
1
4
3
.0
0
×
1
0
−
2
L
ef
t.
T
h
al
am
u
s.
P
ro
p
er
-0
.3
2
-0
.1
1
-0
.0
1
6.
2
8
×
1
0
−
9
7
2.
6
5
×
1
0
−
1
3
0
.4
8
L
ef
t.
C
er
eb
el
lu
m
.C
or
te
x
-0
.2
6
-0
.0
7
-0
.0
3
1
.9
8
×
1
0−
6
5
5.
0
1
×
1
0
−
6
9
.0
2
×
1
0
−
2
B
ra
in
.S
te
m
-0
.2
3
-0
.0
6
-0
.0
2
1.
1
5
×
1
0
−
4
8
1.
6
0
×
1
0
−
5
0
.1
3
L
ef
t.
C
au
d
at
e
0.
07
0.
04
0.
03
7.
8
9
×
1
0−
6
1.
9
3
×
1
0
−
2
0
.1
2
L
ef
t.
C
er
eb
el
lu
m
.W
h
it
e.
M
at
te
r
-0
.3
0
-0
.0
3
0.
00
1.
6
0
×
1
0
−
7
4
0.
1
0
0
.8
6
L
ef
t.
P
al
li
d
u
m
-0
.0
6
-0
.0
2
-0
.0
4
4.
8
4
×
1
0−
4
0.
2
3
1
.3
1
×
1
0
−
2
4t
h
.V
en
tr
ic
le
0.
09
0.
00
-0
.0
8
2.
3
8
×
1
0
−
7
0.
8
3
1
.1
3
×
1
0
−
5
L
ef
t.
ve
ss
el
0.
12
0.
00
-0
.0
2
1.
0
5
×
1
0
−
1
2
0
.9
3
0
.3
7
ly. The ROC curves in figure 8 and the box plots in figure
9 confirm these observations.
3.3.3. Experiment 3: ABIDE II Dataset
For our third experiment, we evaluate the age predic-
tion on the ABIDE II dataset that contains subjects with
autism. To the best of our knowledge, no previous age pre-
diction based approach has been used for studying autism.
However, previous studies have suggested abnormal brain
development in patients diagnosed with autism Courch-
esne et al. (2001). By observing figures 11 and 10 it is
clear that differences between HC and MCI groups are
considerably less noticeable than in the previous two ex-
periments. In fact, by analyzing the AUC results in ta-
ble 10 and the p-values in table 9, we can observe that
no significant differences between groups were found us-
ing the standard prediction error approach using  as a
predictive variable. In contrast, both uncertainty based
measurements showed significant differences between HC
and autistic groups. Also different to the previous two ex-
periments, the weighted uncertainty based measurement
covw(yˆ) showed a better performance than the standard
uncertainty cov(yˆ). In this case correlation coefficients
between the metrics were 0.64 for cov(yˆ)-covw(yˆ), 0.30
for -cov(yˆ) and 0.49 for -covw(yˆ). The lower correla-
tion between cov(yˆ)-covw(yˆ) and the larger correlation
between -covw(yˆ) when compared to the two previous
experiments are caused by the smaller value of ly.
4. Discussion
In this work, we have proposed to use uncertainty in
GPR as a measure of neuropathology. In contrast to pre-
vious work based on the prediction error, which assumes
similar trajectories between aging and disease processes,
the GPR uncertainty handles differences in morphology of
diseased brains that do not necessarily lie on a healthy ag-
ing trajectory. If we consider predicted age as an aging
biomarker, GPR uncertainty can be seen as a measure of
uncertainty of the aging biomarker. We have evaluated the
ability of GPR uncertainty to discriminate subjects with
pathology for two very different diseases: Alzheimer’s dis-
ease where we worked with a cohort of advanced age in-
dividuals, and autism where we operated on a younger
cohort. To the best of our knowledge, this is the first time
that uncertainty in a GPR model is used as a measure of
neuropathology and it is also the first application of an
age regression model for autism. For both applications,
we work with a single model that was trained on healthy
subjects from a wide age range. This distinguishes our
work from discriminative approaches, which require the
inclusion of images of patients diagnosed with a particular
disease in the training set.
In this work, we build age prediction models using three
different types of brain features: VBM, volume and thick-
ness as well as a combination of all of them. Based on
11
Feature Set MAE R2
Volume 5.52 0.87
Thickness 6.50 0.80
VBM 5.65 0.86
All 3.86 0.93
Table 4: Mean Absolute Error (MAE) and R2 score of the age prediction models trained with different sets of features. Measurements are
obtained using a 5-fold cross validation on the training set.
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Figure 8: Receiver Operating Characteristic (ROC) curves for the prediction of the presence of MCI/AD (Top) or the presence of AD (Bottom)
evaluated on the OASIS dataset. Columns correspond to the different evaluated features.
HC-MCI MCI-AD
 cov(yˆ) covw(yˆ)  cov(yˆ) covw(yˆ)
Volume 6.82× 10−19 2.07× 10−29 1.85× 10−31 3.36× 10−60 4.54× 10−69 2.05× 10−74
Thickness 2.18× 10−18 3.53× 10−27 2.92× 10−24 3.98× 10−38 6.03× 10−105 1.45× 10−101
VBM 3.10× 10−7 6.12× 10−30 1.20× 10−34 5.61× 10−22 2.92× 10−77 1.17× 10−76
All 5.63× 10−5 5.16× 10−36 5.10× 10−37 9.46× 10−23 2.76× 10−103 1.02× 10−103
Table 5: p-values corresponding to the statistical tests performed
on the experiments comparing the HC, MCI and AD groups on the
ADNI dataset.
HC-MCI MCI-AD
 cov(yˆ) covw(yˆ)  cov(yˆ) covw(yˆ)
Volume 0.67 0.71 0.72 0.73 0.76 0.77
Thickness 0.66 0.71 0.71 0.69 0.80 0.80
VBM 0.60 0.71 0.72 0.64 0.77 0.77
All 0.59 0.74 0.74 0.64 0.81 0.81
Table 6: Area Under the Curve (AUC) values corresponding to the
statistical tests performed on the experiments comparing the HC,
MCI and AD groups on the ADNI dataset.
our results, we have observed that none of the features
outperformed the others across all our evaluations. How-
ever, combining all features resulted on a model with the
lowest prediction error and consistently achieved the best
results when performing separation between healthy and
disease groups. This is in line with previous work (Val-
izadeh et al., 2017; Liem et al., 2017), where it has been
HC-MCI MCI-AD
 cov(yˆ) covw(yˆ)  cov(yˆ) covw(yˆ)
Volume <0.0001 <0.0001 < 0.0001 0.0611 0.0065 0.0067
Thickness 0.0005 0.1186 0.1123 0.0707 0.0002 0.0002
VBM 0.0075 <0.0001 <0.0001 0.0225 0.0003 0.0003
All 0.0015 <0.0001 < 0.0001 0.0707 0.0020 0.0020
Table 7: p-values corresponding to the statistical tests performed
on the experiments comparing the HC, MCI and AD groups on the
OASIS dataset. The highlighted values correspond to p values with
significance levels under 0.05 (light background), 0.01 (middle back-
ground) and 0.001 (dark background).
observed that extended feature sets which give models a
larger variety of measurements to base the prediction on,
result in more accurate age estimation models. Although
the main goal of this paper is not to present a state-of-
the-art age prediction method, we have observed that our
proposed GPR model has a high prediction accuracy, com-
parable to that of current age estimation approaches (Val-
izadeh et al., 2017; Cole et al., 2016).
We have also demonstrated the generalization ability
of our method by training and testing our model in com-
pletely independent datasets. Our training dataset was
built based on the IXI, ABIDE and AIBL databases while
testing was performed on the OASIS, ADNI and ABIDE
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Figure 9: Box plots showing prediction results for  (top), cov(yˆ) (middle) and covw(yˆ) (bottom) for HC, MCI and AD groups on the OASIS
dataset. Columns correspond to the different evaluated features.
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Figure 10: Receiver Operating Characteristic (ROC) curves for the prediction of the presence of Autism. Columns correspond to the different
evaluated features.
HC-MCI MCI-AD
 cov(yˆ) covw(yˆ)  cov(yˆ) covw(yˆ)
Volume 0.77 0.73 0.73 0.73 0.75 0.75
Thickness 0.68 0.62 0.62 0.68 0.76 0.76
VBM 0.64 0.72 0.72 0.68 0.77 0.77
All 0.67 0.74 0.74 0.68 0.77 0.77
Table 8: Area Under the Curve (AUC) values corresponding to the
statistical tests performed on the experiments comparing the HC,
MCI and AD groups on the OASIS dataset.
II databases. Using different datasets for training and
testing complicates the age prediction problem, as unde-
sired dataset biases can impact the result (Wachinger and
Reuter, 2016; Gutie´rrez et al., 2017). However, such ex-
periments model a scenario that is more realistic, as the
translation to the clinic requires the accurate deployment
 cov(yˆ) covw(yˆ)
Volume 0.3210 <0.0317 <0.0019
Thickness 0.4664 <0.0001 <0.0001
VBM 0.0556 0.0089 <0.0001
All 0.1060 <0.0001 <0.0001
Table 9: p-values corresponding to the statistical tests performed on
the experiments comparing the HC, and Autism groups. The high-
lighted values correspond to p values with significance levels under
0.05 (light background), 0.01 (middle background) and 0.001 (dark
background).
of our method on data that differs from the training set.
Based on GPR uncertainty, we have introduced two
metrics to assess the similarity of a test subject to a model
of healthy aging: the uncertainty of the predictions of
the GPR cov(yˆ) and an age-weighted uncertainty mea-
surement covw(yˆ). We have shown in our experiments
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Figure 11: Box plots showing prediction results for  (top), cov(yˆ) (middle) and covw(yˆ) (bottom) for HC and Autism groups on the ABIDE
II dataset. Columns correspond to the different evaluated features.
 cov(yˆ) covw(yˆ)
Volume 0.50 0.53 0.58
Thickness 0.50 0.60 0.60
VBM 0.53 0.55 0.60
All 0.53 0.58 0.60
Table 10: Area Under the Curve (AUC) values corresponding to the
statistical tests performed on the experiments comparing the HC,
and Autism groups on the ABIDE II dataset.
in section 3 that both measures find statistically signifi-
cant differences between HC, MCI and AD groups as well
as between autism and HC groups. We have compared
these results to the commonly used prediction error , and
we have shown that the proposed metrics yield a better
separation between groups. The age-weighted uncertainty
measurement can be seen as an extension to the standard
uncertainty measure, with the inclusion of a weighting pa-
rameter based on the chronological age of the test sub-
ject. The effect of this weighting is controlled by the age-
length scale parameter ly. We have analyzed the effect
of ly in the performance of the age-weighted uncertainty
measurement and we have observed that although the use
of the age-weighting had a limited effect in the case of
the MCI/AD experiments there was a clear improvement
in the case of autism. We hypothesize that these differ-
ences in performance of covw(yˆ) can be attributed to the
different age ranges of the testing cohorts, since age predic-
tion models present smaller prediction errors when testing
on younger cohorts compared to the prediction error pre-
sented on datasets consisting of older individuals (Cole and
Franke, 2017).
For the experiment on autism, our proposed uncer-
tainty based metrics showed its ability to discriminate be-
tween autistic and healthy groups. We find these results
particularly encouraging since the prediction error based
approach showed to be insufficient to find differences for
this particular disease. Given the analysis performed in
section 3.1 and the results of our experiments, we believe
that the main reason of the better performance of our un-
certainty based measures is that they do not model brain
anomaly as an accelerated aging process, but rather as
deviations from healthy aging. As discussed before, the
complex effects of aging and disease follow trajectories that
affect different areas of the brain at different rates. The
more relaxed assumptions, which our proposed uncertainty
based measures are based on, are therefore better suited
to account for the complex impact of aging and disease
across the entire brain.
We have not performed direct quantitative compar-
isons between our uncertainty based measures and dis-
criminative approaches. The main reason behind this is
that discriminative approaches require training images not
only from healthy individuals but also from patients. This
means that separate models have to be trained for each
specific disease. In contrast, age-prediction based models
are only built on images from healthy individuals. This
allows to have a flexible model which can be used for dif-
ferent diseases without any need to retrain or adjust the
model. We demonstrated this in our experiments, where
we used the same age prediction model to predict brain
anomaly both on patients with Alzheimer’s disease and
14
patients with autism.
5. Conclusions
We introduced the prediction uncertainty in age esti-
mation as a measure of neuropathology, based on a mul-
tivariate age prediction model based on Gaussian process
regression. Our measure does not make a priori specific as-
sumptions about the nature of the changes caused by dis-
ease, but rather models these changes as deviations from
healthy aging. The method is therefore not limited to a
specific pathology or age range, as demonstrated in our
experiments on patients with Alzheimer’s disease and pa-
tients with autism. Our method is also flexible to work
with different sets of features, as we have illustrated in our
experiments using volume, thickness, and VBM features.
We have introduced an extension of the Gaussian process
uncertainty measure for age estimation that also takes the
chronological age into account, resulting in a weighted un-
certainty measure, and we have demonstrated that the in-
clusion of this weighted measure can potentially be help-
ful for some applications. In comparison to the commonly
used prediction error, the prediction uncertainty yielded
an improved separation of diagnostic groups across all fea-
ture types and for different applications. It is also impor-
tant to point out that in contrast to discriminative ap-
proaches, age prediction based models only require images
of healthy individuals for training, which may allow for in-
corporating scans from large population-based studies in
the future. The results presented in this paper encourage
us to further explore the potential of uncertainty based
measures and to apply our method to different diseases or
conditions that might have complex effects in the anatomy
of the brain. We are further interested in investigating the
relationship between the prediction uncertainty and cog-
nitive and clinical characteristics, as well as, future health
outcomes.
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